{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T06:55:39Z","timestamp":1763016939466},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1097\/dad.0b013e3181660665","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T16:53:26Z","timestamp":1236272006000},"page":"172-173","source":"Crossref","is-referenced-by-count":7,"title":["Hand-Foot Syndrome With Sclerodactyly-Like Changes in a Patient Treated With Capecitabine"],"prefix":"10.1097","volume":"30","author":[{"given":"Felicidade","family":"Trindade","sequence":"first","affiliation":[]},{"given":"Rosario","family":"Haro","sequence":"additional","affiliation":[]},{"given":"Maria Carmen","family":"Fari\u00f1a","sequence":"additional","affiliation":[]},{"given":"Luis","family":"Requena","sequence":"additional","affiliation":[]}],"member":"276","reference":[{"key":"R3-16-20210202","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3904\/kjim.2007.22.2.109","article-title":"Hand-foot syndrome with scleroderma-like change induced by the oral capecitabine: a case report.","volume":"22","author":"Lee","year":"2007","journal-title":"Korean J Intern Med"},{"key":"R4-16-20210202","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.clinthera.2005.01.005","article-title":"Capecitabine: a review.","volume":"27","author":"Walko","year":"2005","journal-title":"Clin Ther"},{"key":"R5-16-20210202","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1634\/theoncologist.7-4-288","article-title":"Clinical studies of three oral prodrugs of 5-fluorouracil (capecitabine, UFT, S-1): a review.","volume":"7","author":"Malet-Martino","year":"2002","journal-title":"Oncologist"},{"key":"R6-16-20210202","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1159\/000063905","article-title":"Eruptive multiple lentigo-maligna-like lesions in a patient undergoing chemotherapy with an oral 5-fluorouracil prodrug for metastasizing colorectal carcinoma: a lesson for the pathogenesis of malignant melanoma?","volume":"205","author":"Bogenrieder","year":"2002","journal-title":"Dermatology"},{"key":"R7-16-20210202","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1067\/mjd.2002.122745a","article-title":"Photoeruption in a patient treated with capecitabine (Xeloda) for metastatic breast cancer.","volume":"47","author":"Willey","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"R8-16-20210202","first-page":"202","article-title":"Capecitabine-induced cutaneous hyperpigmentation: report of a case.","volume":"1","author":"Pui","year":"2002","journal-title":"J Drugs Dermatol"},{"key":"R9-16-20210202","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1067\/mjd.2001.117244","article-title":"Mucositis as a treatment-limiting side effect in the use of capecitabine for the treatment of metastatic breast cancer.","volume":"45","author":"Bell","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"R10-16-20210202","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1001\/archderm.140.3.367","article-title":"Inflammation of actinic keratoses during capecitabine therapy.","volume":"140","author":"Lewis","year":"2004","journal-title":"Arch Dermatol"},{"key":"R11-16-20210202","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1200\/JCO.1999.17.2.485","article-title":"Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer.","volume":"17","author":"Blum","year":"1999","journal-title":"J Clin Oncol"},{"key":"R12-16-20210202","doi-asserted-by":"crossref","first-page":"798","DOI":"10.7326\/0003-4819-101-6-798","article-title":"Chemotherapy-associated palmar-plantar erythrodysesthesia syndrome.","volume":"101","author":"Lokich","year":"1984","journal-title":"Ann Intern Med"},{"key":"R13-16-20210202","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0190-9622(91)70073-B","article-title":"Chemotherapy-induced acral erythema.","volume":"24","author":"Baack","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"R14-16-20210202","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1002\/1097-0142(19950415)75:8<2169::AID-CNCR2820750822>3.0.CO;2-H","article-title":"Hand-foot syndrome associated with liposome-encapsulated doxorubicin therapy.","volume":"75","author":"Gordon","year":"1995","journal-title":"Cancer"},{"key":"R15-16-20210202","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2165\/00128071-200001040-00004","article-title":"Antineoplastic therapy-induced palmar plantar erythrodysesthesia (Hand-Foot) syndrome: Incidence, recognition and management.","volume":"1","author":"Nagore","year":"2000","journal-title":"Am J Clin Dermatol"},{"key":"R16-16-20210202","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1177\/1078155206069242","article-title":"Management of hand-foot syndrome induced by capecitabine.","volume":"12","author":"Gressett","year":"2006","journal-title":"J Oncol Pharm Pract"}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00000372-200804000-00016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T05:58:52Z","timestamp":1618034332000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000372-200804000-00016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0b013e3181660665","relation":{},"ISSN":["0193-1091"],"issn-type":[{"value":"0193-1091","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}